COMPLIANCE OF CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TUMOR PATIENTS WITH SURVEILLANCE
- 1 September 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 160 (3 Part 1) , 768-771
- https://doi.org/10.1016/s0022-5347(01)62782-4
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.Journal of Clinical Oncology, 1997
- Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumorsAnnals of Surgical Oncology, 1996
- A Surveillance Study of Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: 10-Year FollowupJournal of Urology, 1995
- Complications of primary retroperitoneal lymph-node dissection for low-stage testicular cancerWorld Journal of Urology, 1994
- Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.Journal of Clinical Oncology, 1992
- Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group.Journal of Clinical Oncology, 1991
- Compliance with follow-up of patients treated for non-seminomatous testicular cancerBritish Journal of Cancer, 1991
- Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial.Journal of Clinical Oncology, 1990
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958